Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 0 | 0 | 654 | 5,278 |
| Gross Profit | N/A | N/A | N/A | 654 | 5,278 |
| Operating Expenses | 129,586 | 136,218 | 119,907 | 109,720 | 90,314 |
| Operating Income | -129,586 | -136,218 | -119,907 | -109,066 | -85,036 |
| Other Income | 16,432 | 17,099 | 16,744 | 11,492 | 9,714 |
| Pre-tax Income | -113,154 | -119,119 | -103,163 | -97,574 | -75,322 |
| Income Tax | N/A | N/A | N/A | N/A | 890 |
| Net Income Continuous | -113,824 | -119,119 | -103,163 | -97,574 | -76,212 |
| Net Income | $-113,824 | $-119,119 | $-103,163 | $-97,574 | $-76,212 |
| EPS Basic Total Ops | -3.02 | -3.16 | -2.75 | -2.80 | -2.24 |
| EPS Basic Continuous Ops | -3.02 | -3.16 | -2.75 | -2.80 | -2.23 |
| EPS Diluted Total Ops | -3.02 | -3.16 | -2.75 | -2.80 | -2.24 |
| EPS Diluted Continuous Ops | -3.02 | -3.16 | -2.75 | -2.80 | -2.23 |
| EPS Diluted Before Non-Recurring Items | -3.01 | -3.16 | -2.75 | -2.80 | -2.22 |
| EBITDA(a) | $-139,538 | $-146,671 | $-128,789 | $-116,044 | $-89,411 |